In summary, PDE inhibitors besides their anti-inflammatory and bronchodilator properties can prevent recurrent infection, persistent inflammation, and decline in lung functions via direct cilia-stimulatory response, when cilia dysfunction in lung diseases has developed. Here, ALDH7A1 is linked to lung disorder.